Improving Everyday Memory in At-Risk Elderly

National Institute on Aging (NIA)1 site in 1 country260 target enrollmentMarch 2001

ConditionsAging

Overview

Phase: Phase 3
Intervention: Not specified
Conditions: Aging
Sponsor: National Institute on Aging (NIA)
Enrollment: 260
Locations: 1
Status: Completed
Last Updated: 16 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to determine whether classes on memory training will help older adults to improve or maintain their daily activities.

Detailed Description

Volunteer participants will be randomly assigned to experimental (memory training) and comparison (health promotion) groups. Both groups will learn strategies for successful aging. Participants will be in the study for 27 months and will be interviewed on five occasions for 3 hours per interview. The classroom-based intervention is an 8-session, 1 1/2 hour course designed to teach older adults the use of strategies to improve everyday memory. Strategically-placed booster sessions will be provided to subjects within 3 months following the last class session.

Registry

clinicaltrials.gov

Start Date

March 2001

End Date

February 2006

Last Updated

16 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

National Institute on Aging (NIA)

Eligibility Criteria

Inclusion Criteria

•Reside in Austin, Texas or Travis County
•African, Caucasian, or Hispanic heritage
•Fluent in reading and speaking English
•Mini Mental Exam scores of 23-30
•Pass executive function test
•Adequate hearing and vision to enable participation in classroom learning
•Free of Alzheimer's disease or other conditions (e.g., certain cancers) likely to result in mortality before study completion

Exclusion Criteria

•Score less than 23 on MMSE
•Fail the executive function tests
•Severe sensory losses, hearing or vision, that would prohibit testing or participation
•self-report a diagnosis of Alzheimer's disease or other conditions (e.g., certain cancers) likely to result in mortality before study completion